Safety and Feasibility of Intra-Arterial Nicardipine for the Treatment of Subarachnoid Hemorrhage-Associated Vasospasm: Initial Clinical Experience with High-Dose Infusions

References

1. ↵
   Biondi A, Ricciardi G, Puybasset L, et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 2004;25:1067–76

   Abstract/FREE Full Text
2. ↵
   Macdonald RL, Weir B. Epidemiology. In: Cerebral Vasospasm. San Diego: Academic Press;2004 :16–18
3. ↵
   Milburn JM, Moran CJ, Cross DT, et al. Effect of intraarterial papaverine on cerebral circulation time. AJNR Am J Neuroradiol 1997;18:1081–85

   Abstract
4. ↵
   Feng L, Fitzsimmons BF, Young WL, et al. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol 2002;23:1284–90

   Abstract/FREE Full Text
5. ↵
   Badjatia N, Topcuoglu MA, Pryor JC, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 2004;25:819–26

   Abstract/FREE Full Text
6. ↵
   Abe K, Iwanaga H, Inada E. Effect of nicardipine and diltiazem on internal carotid artery blood flow velocity and local cerebral blood flow during cerebral aneurysm surgery for subarachnoid hemorrhage. J Clin Anesth 1994;6:99–105

   PubMedWeb of Science
7. Alabad JA, Salom JB, Torregrosa G, et al. Changes in the cerebrovascular effects of endothelin-1 and nicardipine after experimental subarachnoid hemorrhage. Neurosurgery 1993;33:707–15

   PubMedWeb of Science
8. Frazee J, Bevan JA, Bevan RD, et al. Early treatment with diltiazem reduces delayed cerebral vascular narrowing after subarachnoid hemorrhage. Neurosurgery 1988;23:611–15

   PubMed
9. ↵
   Takayasu M, Suzuki Y, Shibuya M, et al. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J Neurosurg 1986;65:80–85

   PubMedWeb of Science
10. ↵
    Yoshida K, Watanabe H, Nakamura S. Intraarterial injection of amrinone for vasospasm induced by subarachnoid hemorrhage. AJNR Am J Neuroradiol 1997;18:492–96

    Abstract
11. ↵
    Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. BMJ 1989;298:636–42

    Abstract/FREE Full Text
12. ↵
    Flamm ES, Adams HP Jr, Beck DW, et al. Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1988;68:393–400

    PubMedWeb of Science
13. ↵
    Haley EC, Kassell NF, Torner JC, et al. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage: a report of the Cooperative Aneurysm Study. J Neurosurg 1993;78:537–47

    PubMedWeb of Science
14. Haley EC, Kassell NF, Torner JC, et al. A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results: a report of the Cooperative Aneurysm Study. J Neurosurg 1993;78:548–53

    PubMedWeb of Science
15. ↵
    Haley EC, Kassell NF, Torner JC, et al. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage: a report of the Cooperative Aneurysm Study. J Neurosurg 1994;80:788–96

    PubMed
16. ↵
    Nogueria RG, Lev MH, Roccatagliata L, et al. Effects of intraarterial nicardipine on cerebral blood flow of patients with subarachnoid hemorrhage-induced vasospasm as measured by cine CT perfusion. 41st Annual American Society of Neuroradiology Meeting; April 27–May 2,2003; Washington, DC
17. ↵
    Kasuya H, Onsa H, Takeshita M, et al. Efficacy and safety of nicardipine prolonged release implants for preventing vasospasm in humans. Stroke 2002;33:1011–15

    Abstract/FREE Full Text